Halozyme Therapeutics Inc (NASDAQ:HALO)
| 38.17 Delayed Data As of Mar 29 |  +1.68 / +4.60%Today’s Change | 32.83 Today|||52-Week Range 59.46 | -32.92% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 135.1M | 146.7M | 316.6M | 151.9M | |
| Cost of Goods Sold | 27.6M | 30.8M | 29.0M | 7.7M | ||
| Depreciation And Amortization | 1.7M | 2.4M | 2.2M | 2.4M | ||
| Operating Expenses | Gross Income | 105.8M | 113.5M | 285.5M | 141.7M | |
| General Expenses | 133.3M | 196.7M | 204.5M | 255.3M | ||
| Research And Development | 93.2M | 150.8M | 150.6M | 194.5M | ||
| Total Operating Expenses | 162.5M | 229.9M | 235.6M | 265.4M | ||
| Non-Operating Expenses | Operating Income | -27.5M | -83.2M | 81.0M | -113.5M | |
| Interest Expense On Debt | 5.2M | 20.0M | 22.0M | 18.0M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -32.2M | -101.9M | 61.6M | -124.0M | |
| Income Taxes | 0.00 | -1.2M | -1.4M | -43.7M | ||
| Net Income | -32.2M | -103.0M | 63.0M | -80.3M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 126.7M | 128.0M | 136.4M | 143.6M | |
| Shares To Calculate EPS Diluted | 126.7M | 128.0M | 139.1M | 143.6M | ||
| Earnings Per Share | EPS | -$0.25 | -$0.81 | $0.45 | -$0.56 | |
| EPS Diluted | -$0.25 | -$0.81 | $0.45 | -$0.56 | ||
